Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Iono Pharma
AddedFeb 17, 2024
UpdatedJun 18, 2026
Iono Pharma

Iono Pharma

Seed

Iono Pharma: Transforming FDA-approved compounds into pediatric-friendly pharmaceuticals.

HQ
Memphis, TN, US
Founded
2012
Overview
Compare
Fundraising
Employees

Iono Pharma is a pharmaceutical company based in Memphis, Tennessee, dedicated to transforming FDA-approved compounds into pediatric-friendly drug delivery systems. Their core mission is to enhance pediatric healthcare by making medications more accessible and easier for children to take. The company focuses on innovative drug delivery solutions tailored specifically for young patients.

Iono Pharma has made significant strides in pediatric healthcare by developing user-friendly pharmaceutical products that address the unique needs of children. Their impact is evident in the improved compliance and outcomes in pediatric treatments. The company continues to advance its mission, contributing to better health and well-being for children.

Iono Pharma - Similar Companies

Ionia Pharmacy logo

Ionia Pharmacy

Pono Pharma logo

Pono Pharma

Iontera logo

Iontera

KinderPharm logo

KinderPharm

Eton Pharmaceuticals logo

Eton Pharmaceuticals

PleoPharma logo

PleoPharma

pleopharma.com

OurPharma Holdings logo

OurPharma Holdings

ourpharma.net

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

ionispharma.com

White Sands Pharma logo

White Sands Pharma

i2o Therapeutics logo

i2o Therapeutics

i2obio.com

Ikaria logo

Ikaria

Therio logo

Therio

ONO Pharmaceutical logo

ONO Pharmaceutical

Nuro Pharma logo

Nuro Pharma

Ivrea Pharmaceuticals logo

Ivrea Pharmaceuticals

Iono Pharma - Quick Facts

Who are Iono Pharma's competitors?

Companies similar to Iono Pharma include Ionia Pharmacy, Pono Pharma, Iontera and KinderPharm.

When was Iono Pharma founded?

Iono Pharma was founded in 2012.

Where is Iono Pharma's headquarters located?

Iono Pharma's headquarters is located in Memphis, TN, US.

When was Iono Pharma's last funding round?

Iono Pharma's most recent funding round was for $20k (USD) in September 2012.

How much has Iono Pharma raised to-date?

As of Sep 1, 2012, Iono Pharma has raised a total of $20k (USD).

How many employees does Iono Pharma have?

Iono Pharma has 5 employees as of Feb 4, 2024.

Iono Pharma - Classification

Ownership
  • Private
Technology
  • HealthTech
  • SaaS
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Software
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research